Shanghai, China

Nanyang Chen

This inventor holds 1 USPTO granted patent and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Shanghai Simr Biotechnology Co., Ltd., Shanghai Simrd Biotechnology Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nanyang Chen. Retrieved from https://idiyas.com/inventor/nanyang-chen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nanyang Chen - Innovator in Pharmaceutical Chemistry

Introduction

Nanyang Chen is an inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds. Although he currently holds no granted patents, his work in the industry is noteworthy.

Latest Patent Applications

Nanyang Chen has submitted several patent applications, including:

1. **Imidazopyridazine Derivative, and Preparation Method Therefor, Pharmaceutical Composition Thereof and Use Thereof** - This application provides an imidazopyridazine derivative, along with a preparation method, a pharmaceutical composition, and its use as a GABA receptor modulator.

2. **Triazolopyridazine Derivative, Preparation Method Therefor, Pharmaceutical Composition Thereof, and Use Thereof** - This application details a triazolopyridazine derivative, its preparation method, and its pharmaceutical applications, highlighting its excellent properties and promising application prospects.

Conclusion

Nanyang Chen's innovative work in pharmaceutical chemistry showcases his dedication to advancing the field, despite not having granted patents at this time. His latest patent applications reflect his commitment to developing new therapeutic compounds.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…